Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Lung Neoplasms and POLE[original query] |
---|
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Human molecular genetics 2007 Oct 16 (19): 2333-40. Matakidou Athena, el Galta Rachid, Webb Emily L, Rudd Matthew F, Bridle Helen, , Eisen Tim, Houlston Richard |
Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. International journal of molecular epidemiology and genetics 2012 3 (1): 1-17. Sakoda Lori C, Loomis Melissa M, Doherty Jennifer A, Julianto Liberto, Barnett Matt J, Neuhouser Marian L, Thornquist Mark D, Weiss Noel S, Goodman Gary E, Chen C |
Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer. Scientific reports 2017 Sep 7 (1): 11785. Song Xiao, Wang Shiming, Hong Xuan, Li Xiaoying, Zhao Xueying, Huai Cong, Chen Hongyan, Gao Zhiqiang, Qian Ji, Wang Jiucun, Han Baohui, Bai Chunxue, Li Qiang, Wu Junjie, Lu Da |
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Molecular cancer 2018 Apr 17 (1): 81. Liu Liang, Ruiz Jimmy, O'Neill Stacey S, Grant Stefan C, Petty W Jeffrey, Yang Meng, Chen Kexin, Topaloglu Umit, Pasche Boris, Zhang W |
Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 57-61. Song Zhengbo, Cheng Guoping, Xu Chunwei, Wang Wenxian, Shao Yang, Zhang Yipi |
Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population. Scientific reports 2019 11 9 (1): 15767. Yao Jianfei, Gong Yuan, Zhao Wei, Han Zhifeng, Guo Shaohua, Liu Hongyi, Peng Xiumei, Xiao Wenhua, Li Yuemin, Dang Shiying, Liu Guifeng, Li Lifeng, Huang Tanxiao, Chen Shifu, Song Le |
Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies. International journal of cancer 2019 Oct . Qian Jie, Nie Wei, Lu Jun, Zhang Lele, Zhang Yanwei, Zhang Bo, Wang Shuyuan, Hu Minjuan, Xu Jianlin, Lou Yuqing, Dong Yu, Niu Yanjie, Yan Bo, Zhong Runbo, Zhang Wei, Chu Tianqing, Zhong Hua, Han Baoh |
Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma. Annals of translational medicine 2022 3 10 (4): 187. Li Jiuzhen, Lin Xuefeng, Li Xin, Zhang Weiran, Sun Daqia |
Integrating POLE/POLD1 mutated for immunotherapy treatment planning of advanced stage non-small cell lung cancer. Thoracic cancer 2023 6 . Shuhua Zheng, Yenong Cao, James Randall, Haomin Yu, Tarita O Thom |
Integrative genomic profiling reveals characteristics of lymph node metastasis in small cell lung cancer. Translational lung cancer research 2023 3 12 (2): 295-311. Kong Kangle, Hu Shan, Yue Jiaqi, Yang Ziheng, Jabbour Salma K, Deng Yu, Zhao Bo, Li F |
Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
- Page last reviewed:Feb 1, 2024
- Content source: